|Bid||0.00 x 21500|
|Ask||0.00 x 27000|
|Day's Range||5.84 - 6.10|
|52 Week Range||4.38 - 30.06|
|Beta (5Y Monthly)||1.57|
|PE Ratio (TTM)||N/A|
|Earnings Date||Sep 29, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar 12, 2020|
|1y Target Est||3.73|
Subscribe to Yahoo Finance Plus to view Fair Value for BBBY
Yahoo Finance Live's Brian Sozzi discusses a Goldman Sachs analyst's decision to reiterate Bed Bath & Beyond stock to Sell.
Bed Bath & Beyond remains in end days and will have major difficulties turning itself around, suggests new research from Goldman Sachs analyst Kate McShane.
Bed Bath & Beyond’s bondholders are organizing, looking to protect their investments in the struggling retailer as it looks for ways to ease its debt during a slump in sales, according to people with knowledge of the matter.